SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

iBio highlights primate study data for IBIO-610

The company said non-human primate study data support IBIO-610’s potential to preserve muscle when combined with GLP-1 therapy.

IBIO